Physician profile
Patrick Garcia
NPI 1487065330
$8,033.22
in general payments reported to CMS, 2019-2025
8 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $1,414 · 2021: $1,760 · 2022: $743 · 2023: $961 · 2024: $1,035 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,104.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,276.34 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Spinal Simplicity, LLC | $1,613.20 | 2021 | |
| Boston Scientific Corporation | $1,597.62 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic USA, INC. | $886.82 | 2019 | |
| Spr Therapeutics, INC | $443.71 | 2021-2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2019 | |
| Vgi Medical, LLC | $75.51 | 2022 | |
| Valinor Pharma, LLC | $15.03 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.